Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-root canal pain control in pulpal necrosis
ACTRN12622000320752Phase 4Not yet recruiting
- Sponsor
- Quratulain Khan
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diclofenac, acetaminophen and ibuprofen in pulpal necrosis (2 arms), sponsored by Quratulain Khan. Primary endpoint: Mean pain score. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
diclofenacacetaminophenibuprofen
03
Conditions
pulpal necrosis
Beyond the preview
Go deeper on ACTRN12622000320752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000320752.